Literature DB >> 22652611

DSM-5 further inflates attention deficit hyperactivity disorder.

Laura Batstra1, Allen Frances.   

Abstract

Since the publication of DSM-IV in 1994, attention deficit hyperactivity disorder (ADHD) prevalence and medication use unexpectedly increased significantly. In this article, we explore the DSM-5 proposals for ADHD that are likely to further increase its prevalence. We also address the possible harmful consequences of further expansion of this already broad, defined, and inflated DSM category.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22652611     DOI： 10.1097/NMD.0b013e318257c4b6

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


  15 in total

Review 1.  Is Adult Attention-Deficit Hyperactivity Disorder Being Overdiagnosed?

Authors:  Joel Paris; Venkat Bhat; Brett Thombs
Journal:  Can J Psychiatry       Date:  2015-07       Impact factor: 4.356

2.  Adult-Onset ADHD: A Critical Analysis and Alternative Explanations.

Authors:  Lea E Taylor; Elizabeth A Kaplan-Kahn; Rachel A Lighthall; Kevin M Antshel
Journal:  Child Psychiatry Hum Dev       Date:  2021-03-18

3.  ADHD in DSM-5: a field trial in a large, representative sample of 18- to 19-year-old adults.

Authors:  B Matte; L Anselmi; G A Salum; C Kieling; H Gonçalves; A Menezes; E H Grevet; L A Rohde
Journal:  Psychol Med       Date:  2014-06-23       Impact factor: 7.723

4.  The design and user-testing of a question prompt list for attention-deficit/hyperactivity disorder.

Authors:  Rana Ahmed; David K Raynor; Kirsten J McCaffery; Parisa Aslani
Journal:  BMJ Open       Date:  2014-12-16       Impact factor: 2.692

5.  Prescription, dispensation and marketing patterns of methylphenidate.

Authors:  Edson Perini; Daniela Rezende Garcia Junqueira; Lorena Gomes Cunha Lana; Tatiana Chama Borges Luz
Journal:  Rev Saude Publica       Date:  2014-12       Impact factor: 2.106

6.  Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria.

Authors:  Geurt van de Glind; Maija Konstenius; Maarten W J Koeter; Katelijne van Emmerik-van Oortmerssen; Pieter-Jan Carpentier; Sharlene Kaye; Louisa Degenhardt; Arvid Skutle; Johan Franck; Eli-Torild Bu; Franz Moggi; Geert Dom; Sofie Verspreet; Zsolt Demetrovics; Máté Kapitány-Fövény; Melina Fatséas; Marc Auriacombe; Arild Schillinger; Merete Møller; Brian Johnson; Stephen V Faraone; J Antoni Ramos-Quiroga; Miguel Casas; Steve Allsop; Susan Carruthers; Robert A Schoevers; Sara Wallhed; Csaba Barta; Peter Alleman; Frances R Levin; Wim van den Brink
Journal:  Drug Alcohol Depend       Date:  2013-10-05       Impact factor: 4.492

Review 7.  Interpreting the inner world of ADHD children: psychoanalytic perspectives.

Authors:  Björn Salomonsson
Journal:  Int J Qual Stud Health Well-being       Date:  2017-06

Review 8.  DSM Nosology Changes in Neuropsychological Diagnoses through the Years: A Look at ADHD and Mild Neurocognitive Disorder.

Authors:  Anne R Carlew; Andrea L Zartman
Journal:  Behav Sci (Basel)       Date:  2016-12-29

Review 9.  Psychiatrization of Society: A Conceptual Framework and Call for Transdisciplinary Research.

Authors:  Timo Beeker; China Mills; Dinesh Bhugra; Sanne Te Meerman; Samuel Thoma; Martin Heinze; Sebastian von Peter
Journal:  Front Psychiatry       Date:  2021-06-04       Impact factor: 4.157

10.  Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptability of drug treatment for depression and ADHD.

Authors:  Brad Partridge; Jayne Lucke; Wayne Hall
Journal:  BMC Psychiatry       Date:  2014-03-13       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.